Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al.
Kristin M D'SilvaNaomi Serling-BoydRachel WallworkTiffany HsuJeffrey A SparksZachary Scott WallacePublished in: Annals of the rheumatic diseases (2020)